Evidence map›Paper›PMID 37408218›Full record

ArticleCells2023

Genetically Engineered Triple

Leonora Szabo, Amandine Grimm, Juan Antonio García-León, Catherine M Verfaillie, Anne Eckert

Open access · goldAbstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Proanthocyanidins from Ginkgo extract EGb 761Frontiers in pharmacology · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Leonora SzaboResearch Cluster Molecular and Cognitive Neurosciences, University of Basel, 4002 Basel, Switzerland.ORCID 0000-0001-5117-3778
Amandine GrimmResearch Cluster Molecular and Cognitive Neurosciences, University of Basel, 4002 Basel, Switzerland.ORCID 0000-0003-3323-1756
Juan Antonio García-LeónDepartamento Biologia Celular, Genetica y Fisiologia, Instituto de Investigacion Biomedica de Malaga-IBIMA, Facultad de Ciencias, Universidad de Malaga, 29071 Malaga, Spain.ORCID 0000-0002-5410-3377
Catherine M VerfaillieDepartment of Development and Regeneration, Stem Cell Institute, KU Leuven, 3000 Leuven, Belgium.
Anne EckertResearch Cluster Molecular and Cognitive Neurosciences, University of Basel, 4002 Basel, Switzerland.ORCID 0000-0002-9341-3669
University of Basel · CHBiomedical Research Networking Center on Neurodegenerative Diseases · ESKU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pathological abnormalities in the tau protein give rise to a variety of neurodegenerative diseases, conjointly termed tauopathies. Several tau mutations have been identified in the tau-encoding gene

Indexed as

Induced Pluripotent Stem Cellstau ProteinsEnergy MetabolismHumansMitochondriaMutationMAPT protein, humantau Proteinsbioenergeticsdynamicsinduced pluripotent stem cellsmitochondriaoxidative stresstau protein

Identifiers

PMID37408218
PMCPMC10216799
OpenAlexW4381592137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.